257 results on '"Mealing, S"'
Search Results
2. From Sea unto Sea: The Road to Nationhood, 1850–1910 by W. G. Hardy (review)
3. I-PreFer Study: A Questionnaire to Explore Patient, Caregiver and Pulmonologist Preferences of Idiopathic Pulmonary Fibrosis Treatment Options
4. I-PreFer Study: A Discrete Choice Experiment to Explore Patient, Caregiver and Pulmonologist Preferences of Idiopathic Pulmonary Fibrosis Pharmacological Treatment Options
5. An economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from a Danish healthcare perspective
6. EE480 Cost-Effectiveness Analysis of an Implantable Device for Chronic Gastro-Oesophageal Reflux Disease in Sweden
7. EE633 Analysis of Cost-Effectiveness in Switzerland for a New Implantable Device to Treat Chronic Gastroesophageal Reflux Disease
8. MSR8 Nesting a Decision Tree into a Markov Model Structure: An Alternative Way of Tracking Movement in a Diagnostic Model
9. EE615 A Cost-Effectiveness Analysis of the CNIC-Polypill Strategy, Compared to Usual Care, in Secondary Cardiovascular Prevention from a Spanish Perspective Using Data from the Secure Trial
10. EE585 Threshold Price Analysis of Micro-Hole Zone Technology Catheters Compared to Standard Hydrophilic-Coated Catheters in Long-Term Intermittent Catheter Users in the UK
11. An economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from a German healthcare service payer perspective
12. Predictive value of residual SYNTAX score for clinical outcomes after High-Risk Percutaneous Coronary Intervention (HR-PCI): Evidence from pooled analysis of prospective studies
13. EVALUATING THE COST-EFFECTIVENESS OF FIRST-LINE CRYOBALLOON ABLATION VERSUS ANTIARRHYTHMIC DRUG THERAPY FOR THE TREATMENT OF PAROXYSMAL ATRIAL FIBRILLATION FROM A CANADIAN HEALTHCARE PAYER PERSPECTIVE
14. An economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from an English NHS perspective
15. Time trade-off study to establish utility decrements in individuals with a spinal cord injury who perform intermittent catheterisation
16. Comparative efficacy of tyrosine kinase inhibitor treatments in the third-line setting, for chronic-phase chronic myelogenous leukemia after failure of second-generation tyrosine kinase inhibitors
17. EE222 Evaluating the Budget Impact on the Health Care System in England and Wales of RefluxStop as a Treatment for Refractory Gastroesophageal Reflux Disease (GORD)
18. EE362 Evaluating the Cost-Effectiveness of Refluxstop as a Treatment for Refractory Gastroesophageal Reflux Disease (GORD)
19. PCR261 Elicitation of Health Utilities Online in Patients With Spinal Muscular Atrophy
20. Systematic literature review assessing the overall costs and societal impacts of moderate‐to‐severe atopic dermatitis in Europe
21. Unveiling the true costs and societal impacts of moderate‐to‐severe atopic dermatitis in Europe
22. Abstract No. 556 Cost-effectiveness of radioembolization with Y-90 glass microspheres versus transarterial chemotherapies in the treatment of intermediate stage hepatocellular carcinoma: a U.S. hospital perspective
23. The cost effectiveness of idelalisib in chronic lymphocytic leukaemia in England and Wales: 222
24. Individual patient data network meta-analysis of mortality effects of implantable cardiac devices
25. EVALUATING THE COST-EFFECTIVENESS OF FIRST-LINE CRYOBALLOON ABLATION VERSUS ANTIARRHYTHMIC DRUG THERAPY FOR THE TREATMENT OF PAROXYSMAL ATRIAL FIBRILLATION FROM A CANADIAN HEALTHCARE PAYER PERSPECTIVE
26. PSY11 Systematic Literature Review to Assess Overall Costs and Societal Impacts of Atopic Dermatitis in Europe
27. PRO67 The Use of Vignettes to Derive Health Utilities for Spinal Muscular Atrophy Type I (SMA-I)
28. PSU3 A Framework for Evaluating the Health and Cost Implications of Antimicrobial Resistance in the Context of Surgical Procedures
29. PCV51 COST-EFFECTIVENESS OF RIVAROXABAN IN THE TREATMENT OF PATIENTS WITH CHRONIC CAD OR PAD IN THE UK
30. PIH11 ECONOMIC EVALUATION OF OSPEMIFENE FOR THE TREATMENT OF VULVOVAGINAL ATROPHY IN THE UNITED KINGDOM
31. Systematic reviews of the effectiveness and cost-effectiveness of multi-channel unilateral cochlear implants for adults
32. Effectiveness of multi-channel unilateral cochlear implants for profoundly deaf children: a systematic review
33. Cost-Effectiveness of a Single Inhaler Triple Therapy vs a Dual Inhaled Corticosteroid Plus Long-Acting Beta Agonist (ICS/LABA) for Patients with Chronic Obstructive Pulmonary Disease (COPD) in the United Kingdom (UK)
34. A Novel Modelling Approach to Evaluate the Cost-Effectiveness of Chronic Obstructive Pulmonary Disease (COPD) Interventions
35. Predicting Quality Adjusted Life Years Using St. George Respiratory Results In Patients With Severe Emphysema Treated with Endobronchial Coils In Addition To Standard of Care Compared To Standard of Care Alone
36. P171 Predicting quality adjusted life years using St. George respiratory results in patients with severe emphysema
37. Novel therapies in chronic lymphocytic leukaemia (CLL): quantifying the impact on patient relevant outcome measures
38. Synthesis of Binary Outcome Data on the Log-Odds and Absolute Risk Scales – A Case Study in Chronic Hepatitis C
39. Multithreading: Turbocharged Cost-Effectiveness Analyses in Microsoft Excel
40. A cost-effectiveness analysis of endoscopic eradication therapy for management of dysplasia arising in patients with Barrett's oesophagus in the United Kingdom.
41. Jesuit Relations and Allied Documents : A Selection
42. THE COST EFFECTIVENESS OF AFAMELANOTIDE FOR THE TREATMENT OF ERYTHROPOIETIC PROTOPORHYRIA
43. Long-Term Cost-Effectiveness of Transanal Irrigation In Patients With Neurogenic Bowel Dysfunction Who Have Failed Standard Bowel Care
44. Time Ratios Or Hazard Ratios: Accelerating Toward A New Approach?
45. Cost-Effectiveness of Ikervis® In Severe Dry Eye Disease In The Uk [Update]
46. The Cost Effectiveness Of Idelalisib In Chronic Lymphocytic Leukaemia In England And Wales
47. Cost-Effectiveness Of Idelalisib Plus Rituximab In Chronic Lymphocytic Leukaemia
48. PRS27 - Cost-Effectiveness of a Single Inhaler Triple Therapy vs a Dual Inhaled Corticosteroid Plus Long-Acting Beta Agonist (ICS/LABA) for Patients with Chronic Obstructive Pulmonary Disease (COPD) in the United Kingdom (UK)
49. PRM80 - A Novel Modelling Approach to Evaluate the Cost-Effectiveness of Chronic Obstructive Pulmonary Disease (COPD) Interventions
50. Cost-effectiveness analysis of cardiac resynchronization therapy in patients with NYHA I and NYHA II heart failure in Spain
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.